TONIX PHARMA HOLDINGS LTD has a total of 84 patent applications. It increased the IP activity by 36.0%. Its first patent ever was published in 2009. It filed its patents most often in United States, Australia and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are HEALOR LTD, NORWOOD IMMUNOLOGY LTD and STEINER MITCHELL S.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 20 | |
#2 | Australia | 13 | |
#3 | EPO (European Patent Office) | 10 | |
#4 | WIPO (World Intellectual Property Organization) | 7 | |
#5 | Canada | 6 | |
#6 | China | 5 | |
#7 | Israel | 4 | |
#8 | Singapore | 4 | |
#9 | Brazil | 3 | |
#10 | Hungary | 3 | |
#11 | Serbia | 3 | |
#12 | Japan | 2 | |
#13 | Mexico | 2 | |
#14 | Taiwan | 1 | |
#15 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Computer technology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Heterocyclic compounds | |
#4 | Microorganisms | |
#5 | Computational chemistry | |
#6 | Peptides | |
#7 | Microorganisms | |
#8 | Electric digital data processing |
# | Name | Total Patents |
---|---|---|
#1 | Lederman Seth | 47 |
#2 | Nebuloni Marino | 26 |
#3 | Colombo Patrizia | 17 |
#4 | Harris Herbert | 8 |
#5 | Fabbroni Serena | 7 |
#6 | Chiarucci Michel | 7 |
#7 | Modena Enrico | 7 |
#8 | Seth Lederman | 6 |
#9 | Harris Herb | 6 |
#10 | Giaffreda Stefano Luca | 5 |
Publication | Filing date | Title |
---|---|---|
WO2021038296A2 | Modified tff2 polypeptides | |
WO2021001458A1 | Anti-cd154 antibodies and uses thereof | |
WO2020194058A1 | Salt forms of s-(n, n-diethylcarbamoyl)glutathione | |
AU2019323764A1 | Methods of treating acute stress disorder and posttraumatic stress disorder | |
AU2019262150A1 | Stem cells comprising synthetic chimeric vaccinia virus and methods of using them | |
SG11202004799TA | Cyclobenzaprine treatment for agitation, psychosis and cognitive decline in dementia and neurodegenerative conditions | |
BR112019013244A2 | tianeptin oxalate salts and polymorphs | |
MX2017003644A | Eutectic formulations of cyclobenzaprine hydrochloride. | |
US2015258197A1 | Eutectic isometheptene mucate | |
US2014336264A1 | Eutectic formulations of cyclobenzaprine hydrochloride and amitriptyline hydrochloride | |
EP3246031A1 | Method for treating neurocognitive dysfunction |